Key Insights

Highlights

Success Rate

86% trial completion

Published Results

28 trials with published results (14%)

Research Maturity

76 completed trials (37% of total)

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.9%

12 terminated out of 203 trials

Success Rate

86.4%

-0.2% vs benchmark

Late-Stage Pipeline

5%

10 trials in Phase 3/4

Results Transparency

37%

28 of 76 completed with results

Key Signals

28 with results86% success12 terminated

Data Visualizations

Phase Distribution

151Total
Not Applicable (47)
Early P 1 (2)
P 1 (48)
P 2 (44)
P 3 (8)
P 4 (2)

Trial Status

Completed76
Recruiting47
Unknown35
Active Not Recruiting16
Terminated12
Not Yet Recruiting10

Trial Success Rate

86.4%

Benchmark: 86.5%

Based on 76 completed trials

Clinical Trials (203)

Showing 20 of 20 trials
NCT04811560Phase 1RecruitingPrimary

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

NCT03779854Phase 2Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT06356922Phase 1Active Not RecruitingPrimary

Study Assessing RLT Using [177Lu]Lu-PentixaTher for Relapsed/Refractory CXCR4+ Acute Leukemia.

NCT02677064RecruitingPrimary

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

NCT07710781Not ApplicableNot Yet Recruiting

Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies

NCT05589896Phase 1Active Not RecruitingPrimary

A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

NCT06795139Not ApplicableCompleted

Pilot of a Trial Enrollment Diversity Dashboard

NCT03810196Not ApplicableRecruitingPrimary

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

NCT07565220Phase 1Recruiting

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

NCT07048730Not ApplicableCompletedPrimary

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

NCT03314974Phase 2RecruitingPrimary

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

NCT07356154Phase 1Recruiting

A Study of Revumenib and Mezigdomide in People With Leukemia

NCT03050268RecruitingPrimary

Familial Investigations of Childhood Cancer Predisposition

NCT07634653Not ApplicableNot Yet Recruiting

Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)

NCT06421155Not ApplicableSuspendedPrimary

Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia

NCT05428176Not ApplicableActive Not RecruitingPrimary

A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors

NCT04013685Phase 1Active Not Recruiting

Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT07616635Phase 3Completed

A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)

NCT04195633Phase 2RecruitingPrimary

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

NCT03434730Phase 2Completed

Tocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation

Scroll to load more

Research Network

Activity Timeline